In relation to AFP-producing lung cancer, it must be kept in mind during the follow-up of these patients that the percentage of cases with poorly differentiated adenocarcinoma and the frequency of a high MIB-1 index are significantly higher in these cases than in those with non-AFP-producing liver cancer [11] during the follow-up of patients. The gene discussed is AFP; the disease is liver cancer.